The Crossroads of Precision Medicine and Therapeutic Decision-Making: Use of an Analytical Computational Platform to Predict Response to Cancer Treatments.

Boichard, Amélie; Richard, Stephane B; Kurzrock, Razelle

Boichard, Amélie; Richard, Stephane B; Kurzrock, Razelle.

Afiliação

Boichard A; Center for Personalized Cancer Therapy, University of California Moores Cancer Center, La Jolla, CA 92093, USA.
Richard SB; CureMatch Inc., San Diego, CA 92121, USA.
Kurzrock R; Center for Personalized Cancer Therapy, University of California Moores Cancer Center, La Jolla, CA 92093, USA.

Cancers (Basel) ; 12(1)2020 Jan 09.

Article em En | MEDLINE | ID: mdl-31936627

Palavras-chave

exceptional responders; molecular pathology; neoplasms; precision medicine; therapeutic decision

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google